Patent details

Basic Information

Publication number:

EP3930703

PCT Application Number:

EP2020054873

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP207057464

PCT Publication Number:

WO2020178074

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ADMINISTRATION REGIMEN OF SOLUTIONS OF T4 THYROID HORMONE WITH HIGH ORAL ABSORPTION

French Title of Invention:

RÉGIME D'ADMINISTRATION DE SOLUTIONS D'HORMONE THYROÏDIENNE T4 À ABSORPTION ORALE ÉLEVÉE

German Title of Invention:

VERABREICHUNGSSCHEMA VON T4-SCHILDDRÜSENHORMONLÖSUNGEN MIT HOHER ORALER ABSORPTION

SPC Number:

Dates

Filing date:

25/02/2020

Grant date:

27/12/2023

EP Publication Date:

05/01/2022

PCT Publication Date:

10/09/2020

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/12/2023

EP B1 Publication Date:

27/12/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

25/02/2024

Expiration date:

25/02/2040

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/12/2023

 

 

Name:

Altergon S.A.

Address:

Via Dogana Vecchia 2, 6900 Lugano, Switzerland (CH)

Inventor

1

Name:

FOSSATI, Tiziano

Address:

Switzerland (CH)

2

Name:

SCARSI, Claudia

Address:

Switzerland (CH)

3

Name:

MAUTONE, Giuseppe

Address:

Switzerland (CH)

Priority

Priority Number:

201900003013

Priority Date:

01/03/2019

Priority Country:

Italy (IT)

Classification

IPC classification:

A61K 31/198; A61K 9/08; A61K 47/10; A61P 5/14;

Publication

European Patent Bulletin

Issue number:

202352

Publication date:

27/12/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages